• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Emergent Biosolutions Inc

+ Add to Watchlist

EBS:US

27.1100 USD 1.2000 4.63%

As of 20:04:06 ET on 12/17/2014.

Snapshot for Emergent Biosolutions Inc (EBS)

Open: 25.8600 Day's Range: 25.5800 - 27.1700 Volume: 299,488
Previous Close: 25.9100 52wk Range: 19.3100 - 28.4800 1-Yr Rtn: +17.61%

Stock Chart for EBS

No chart data available.
  • EBS:US 27.1100
  • 1D
  • 1M
  • 1Y
25.9100
Interactive EBS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EBS

Current P/E Ratio (ttm) 38.1610
Estimated P/E(12/2014) 29.1505
Relative P/E vs. SPX 2.1669
Earnings Per Share (USD) (ttm) 0.7104
Est. EPS (USD) (12/2014) 0.9300
Est. PEG Ratio -
Market Cap (M USD) 1,018.04
Shares Outstanding (M) 37.55
30 Day Average Volume 199,448
Price/Book (mrq) 1.9837
Price/Sale (ttm) 2.5142
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EBS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for EBS

Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.

Fuad El-HibriChairmanDaniel J Abdun-NabiPresident/CEO
Adam HaveyExec VP/President:BiodefenseBarry A LabingerExec VP/Pres:Biosciences Div
More Company Profile & Key Executives for EBS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil